The effect of sildenafil on oesophageal motor function in healthy subjects and patients with nutcracker oesophagus

Neurogastroenterology and Motility

Volumn 15, Issue 6, 2003, Pages 617-623

  Lee, J I ^a   Park, H ^a,c   Kim, J H ^a   Lee, S I ^a   Conklin, J L ^b  

^a Yonsei University College of Medicine   (South Korea)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Cyclic GMP; Nitric oxide; Nutcracker oesophagus; Oesophagus; Phosphodiesterase; Sildenafil

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE; PLACEBO; SILDENAFIL; WATER;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ESOPHAGUS DISEASE; ESOPHAGUS FUNCTION; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS PRESSURE; FEMALE; HIGH AMPLITUDE PERISTALTIC ESOPHAGEAL CONTRACTION; HUMAN; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; MOTOR PERFORMANCE; PERISTALSIS; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

ADULT; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGUS; FEMALE; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PERISTALSIS; PIPERAZINES; STATISTICS, NONPARAMETRIC;

EID: 0348225320     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1350-1925.2003.00450.x     Document Type: Article

References (24)

1. Conklin JL. Nitric oxide: a mediator of esophageal motor function. J Lab Clin Med 1998; 131: 10-20.
2. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL. The effect of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109: 1241-8.
3. Konturek JW, Thor P, Lukaszyk A, Gabryelewicz A, Konturek SJ, Domschke W. Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol 1997; 48: 201-9.
4. v mutant mice. Gastroenterology 2001; 121: 34-42.
5. Hirsch DP, Holloway RH, Typgat GNJ, Boeckxstaens GEE. Involvement of nitric oxide in human transient lower esophageal sphincter relaxation and esophageal primary peristalsis. Gastroenterology 1998; 115: 1374-80.
6. Anand N, Paterson WG. Role of nitric oxide in esophageal peristalsis. Am J Physiol 1994; 266: G123-31.
7. Yamato S, Spechler JS, Goyal RK. Role of nitric oxide in esophageal peristalsis in the opossum. Gastroenterology 1992; 103: 197-204.
8. Shahin W, Murray JA, Clark E, Conklin JL. Role of cGMP as a mediator of nerve-induced motor functions of the opossum esophagus. Am J Physiol 2000; 279: G567-74.
9. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum muscle cells. Life Sci 1998; 62: 309-18.
10. Castell JA. Esophageal manometry. In: Castell DO, ed. The Esophagus, 2nd edn. Boston: Little, Brown, 1995: 133-52.
11. Murray JA, Shibata EF, Buresch TL, Picken H, O'Meara BW, Conklin JL. Nitric oxide modulates a calcium-activated potassium current in muscle cells from opossum esophagus. Am J Physiol 1995; 269: G606-12.
12. Stoschus B, Fernandez I, Heller J, Neubrand M, Sauerbruch T. Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrations. Hepatogastroenterology 1999; 46: 933-7.
13. Kikendall JW, Mellow MH. Effect of sublingual nitroglycerine and long-acting nitrate preparations on esophageal motility. Gastroenterology 1980; 79: 703-6.
14. Luiking YC, Weusten BLAM, Portincasa P, van der Meer R, Smout AJPM, Akkermans LMA. Effect of long-term oral L-arginine on esophageal motility and gallbladder dynamics in healthy humans. Am J Physiol 1998; 274: G984-91.
15. Barnette MS, Barone FC, Fowler PJ, Grous M, Price WJ, Ormsbee HS. Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content. Gut 1991; 32: 4-9.
16. Barnette M, Torphy TJ, Grous M, Fine C, Ormsbee HS. Cyclic GMP: a potential mediator of neurally and drug-induced relaxation of the opossum lower esophageal sphincter. J Pharm Exp Ther 1989; 249: 524-8.
17. Rattan S, Moummi. Influence of stimulators and inhibitors of cyclic nucleotides on the lower esophageal sphincter. J Pharmacol Exp Ther 1989; 248: 703-9.
18. Bortolotti M, Mari C, Giovannini M, Pinna S, Miglioli M. Effects of sildenafil on esophageal motility of normal subjects. Dig Dis Sci 2001; 46: 2301-6.
19. Rhee PL, Hyun JG, Lee JH et al. The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults. Am J Gastroenterol 2001; 96: 3251-7.
20. Eherer AJ, Schwetz I, Hammer HF et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50: 758-64.
21. Murray J, Du C, Ledlow A, Bates JN, Conklin JL. Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol 1991; 261: G401-6.
22. Zhang X, Tack J, Janssens J, Sifirim DA. Effect of sildenafil, a phosphodiesterase-5 inhibitor, on esophageal peristalsis and lower oesophageal sphincter function in cats. Neurogastroenterol Mot 2001; 13: 325-31.
23. Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 2000; 118: 253-7.
24. Gidda JS, Buyniski JP. Swallow-evoked peristalsis in opossum esophagus: role of cholinergic mechanisms. Am J Physiol 1986; 251: G779-85.